- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 59/265 - Citric acid
Patent holdings for IPC class C07C 59/265
Total number of patents in this class: 187
10-year publication summary
|
15
|
20
|
21
|
16
|
9
|
18
|
11
|
16
|
8
|
19
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F.I.S. Fabbrica Italiana Sintetici S.p.A. | 131 |
6 |
| Oyster Point Pharma, Inc. | 75 |
6 |
| Purac Biochem B.V. | 484 |
6 |
| Apotex Inc. | 213 |
5 |
| VeroScience LLC | 68 |
5 |
| Novartis AG | 10595 |
4 |
| Beachbody, LLC | 608 |
4 |
| Tokuyama Corporation | 1435 |
4 |
| Nantong Feiyu Fine Chemical Co., Ltd | 5 |
4 |
| Takeda Pharmaceutical Company Limited | 2726 |
3 |
| Vertex Pharmaceuticals Incorporated | 1629 |
3 |
| Anhui BBCA Fermentation Technology Engineering Research Co., Ltd. | 5 |
3 |
| Gilead Sciences, Inc. | 2110 |
3 |
| Glykon Technologies Group, LLC | 16 |
3 |
| Japan Tobacco Inc. | 3561 |
3 |
| Scynexis, Inc. | 67 |
3 |
| Totus Medicines Inc. | 23 |
3 |
| Ossifi Therapeutics LLC | 12 |
3 |
| Bristol-myers Squibb Company | 4821 |
2 |
| Balchem Corporation | 84 |
2 |
| Other owners | 112 |